StockDuty ← Dashboard Sep 02, 2026 09:57 PM ET
CatalystFDA/Bio

Huahong Grace increase capital for phase 3 of its Wuxi Fab.

Will add 55k wpm of 12-inch capacity. This brings total to $4.17B, which is right in line w/ $7.5 to 8B that a 100k wpm typically requires in China for 28-90nm plant. https://t.co/4bQ0lC1reh — via @tphuang
Phase 3 expansion adds 55k wpm, aligning $4.17B total with China's 28-90nm cost benchmarks.
Sources